Multivalent Vaccines

Global and China Multivalent Vaccines Market Research by Company, Type & Application 2013-2025

Report ID: HeyReport 49911 | Number of pages: 72 | Publish Date: Oct 2019 | Category: Lifesciences and Healthcare
Summary

Market Segment as follows:
By Type
    Conjugate Vaccines
    Inactivated and Subunit Vaccines
    Live Attenuated Vaccines
    Toxoid Vaccines
    Recombinant Vaccines
By Application
    Pediatrics
    Adults
By Company
    GlaxoSmithKline, plc (U.K.)
    Pfizer, Inc. (U.S.)
    Merck & Co., Inc. (U.S.)
    Sanofi Pasteur SA (France)
    Astellas Pharma Inc. (Japan)
    CSL Limited (Australia)
    Emergent BioSolutions, Inc. (U.S.)
    Johnson & Johnson (U.S.)
    MedImmune, LLC (U.S.)
    Serum Institute of India Pvt. Ltd. (India)
    Bavarian Nordic (Denmark)
    Mitsubishi Tanabe Pharma Corporation (Japan)
    Daiichi Sankyo (Japan)
    Protein Sciences Corporation (U.S.)
    Panacea Biotec (India)
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
    1.1 Market Segment Overview
        1.1.1 Product Definition
        1.1.2 Market by Type
            1.1.2.1 Conjugate Vaccines
            1.1.2.2 Inactivated and Subunit Vaccines
            1.1.2.3 Live Attenuated Vaccines
            1.1.2.4 Toxoid Vaccines
            1.1.2.5 Recombinant Vaccines
        1.1.3 Market by Application
            1.1.3.1 Pediatrics
            1.1.3.2 Adults
    1.2 Global and China Market Size
        1.2.1 Global Overview
        1.2.2 China Overview
2 Global and China Market by Company
    2.1 Global
        2.1.1 Global Sales by Company
        2.1.2 Global Price by Company
    2.2 China
        2.2.1 China Sales by Company
        2.2.2 China Price by Company
3 Global and China Market by Type
    3.1 Global
        3.1.1 Global Sales by Type
        3.1.2 Global Price by Type
    3.2 China
        3.2.1 China Sales by Type
        3.2.2 China Price by Type
4 Global and China Market by Application
    4.1 Global
        4.1.1 Global Sales by Application
        4.1.2 Global Price by Application
    4.2 China
        4.2.1 China Sales by Application
        4.2.2 China Price by Application
5 China Trade
    5.1 Export
    5.2 Import
6 Key Manufacturers
    6.1 GlaxoSmithKline, plc (U.K.)
        6.1.1 Company Information
        6.1.2 Product Specifications
        6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    6.2 Pfizer, Inc. (U.S.)
    6.3 Merck & Co., Inc. (U.S.)
    6.4 Sanofi Pasteur SA (France)
    6.5 Astellas Pharma Inc. (Japan)
    6.6 CSL Limited (Australia)
    6.7 Emergent BioSolutions, Inc. (U.S.)
    6.8 Johnson & Johnson (U.S.)
    6.9 MedImmune, LLC (U.S.)
    6.10 Serum Institute of India Pvt. Ltd. (India)
    6.11 Bavarian Nordic (Denmark)
    6.12 Mitsubishi Tanabe Pharma Corporation (Japan)
    6.13 Daiichi Sankyo (Japan)
    6.14 Protein Sciences Corporation (U.S.)
    6.15 Panacea Biotec (India)
7 Industry Upstream
    7.1 Industry Chain
    7.2 Raw Materials
8 Market Environment
    8.1 SWOT
    8.2 Porter's Five Forces
9 Conclusion